STOCK TITAN

TNF Pharmaceuticals, Inc. (TNFA) Net Income by Year

TNFA

TNF Pharmaceuticals, Inc. reported a net loss of $11.6M in fiscal year 2025. This represents an increase of 50.2% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters TNF Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income -$11.6M
YoY +50.2%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TNFA Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13
Net Income-$11.6M+50.2%-$23.4M-484.0%-$4.0M+73.7%-$15.2M+49.2%-$29.9MN/A-$3.9M+64.2%-$10.8M-47.3%-$7.4M-123.0%-$3.3M+64.5%-$9.3M-196.3%-$3.1M-105.9%-$1.5M

TNFA Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'23Q3'23Q2'23
Net Income-$1.2M-10.5%N/A-$2.8M-45.7%-$1.8M+81.2%-$1.1M+88.5%N/A-$1.9M-147.7%-$9.6M-129.5%-$9.8M-548.3%N/A$4.0M+209.5%-$4.2M-14.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More TNF Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was TNF Pharmaceuticals, Inc.'s net income in fiscal year 2025?

TNF Pharmaceuticals, Inc. reported a net loss of $11.6M in fiscal year 2025.

How fast is TNF Pharmaceuticals, Inc.'s net income growing?

TNF Pharmaceuticals, Inc. (TNFA) net income rose by 50.2% year over year, from -$23.4M to -$11.6M in fiscal year 2025.

How has TNF Pharmaceuticals, Inc.'s net income changed over the years?

Across the 13 fiscal years this page covers, TNF Pharmaceuticals, Inc. (TNFA) net income went from -$1.5M in fiscal year 2013 to -$11.6M in fiscal year 2025.

TNF Pharmaceuticals, Inc. (TNFA) reported -$1.2M in net income in Q1 2026. This represents a decrease of 10.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what TNF Pharmaceuticals, Inc. (TNFA) reported on that line in every period on record.